PubRank

F Sobrino

Author PubWeight™ 92.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene 1985 3.42
2 Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 1983 3.04
3 Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J Virol 1994 2.41
4 Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies. J Virol 1991 1.89
5 Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology 1985 1.84
6 Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades. J Virol 1992 1.72
7 Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc Natl Acad Sci U S A 1989 1.71
8 Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem 1999 1.59
9 A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J Gen Virol 1990 1.57
10 Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Gene 1986 1.53
11 Difference in glucose sensitivity of liver glycolysis and glycogen synthesis. Relationship between lactate production and fructose 2,6-bisphosphate concentration. Biochem J 1984 1.49
12 Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J Exp Med 1999 1.45
13 A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol 1997 1.36
14 A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. J Virol 2001 1.29
15 Design of primers for PCR amplification of highly variable genomes. Comput Appl Biosci 1993 1.16
16 Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus. Gene 1988 1.12
17 VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J Virol 1992 1.10
18 Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J Virol 1991 1.07
19 Gene encoding capsid protein VP1 of foot-and-mouth disease virus: a quasispecies model of molecular evolution. Proc Natl Acad Sci U S A 1988 1.05
20 Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology 1999 1.02
21 Deletion or substitution of the aphthovirus 3' NCR abrogates infectivity and virus replication. J Gen Virol 2001 1.01
22 Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression. J Gen Virol 1998 1.00
23 Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine. Virology 1990 0.96
24 In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispecies. J Gen Virol 1998 0.96
25 Immunogenicity of non-structural proteins of foot-and-mouth disease virus: differences between infected and vaccinated swine. Arch Virol 1994 0.95
26 Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J Virol 2001 0.95
27 Comparison of vaccine strains and the virus causing the 1986 foot-and-mouth disease outbreak in Spain: epizootiological analysis. Virus Res 1990 0.95
28 Primer design for specific diagnosis by PCR of highly variable RNA viruses: typing of foot-and-mouth disease virus. Virology 1992 0.95
29 Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. J Gen Virol 1992 0.94
30 Association of bovine DRB3 alleles with immune response to FMDV peptides and protection against viral challenge. Vaccine 2000 0.91
31 Cyclosporin A inhibits phorbol ester-induced activation of superoxide production in resident mouse peritoneal macrophages. Biochem J 1989 0.90
32 Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes. Virus Res 1989 0.90
33 p53 transactivation of the HIV-1 long terminal repeat is blocked by PD 144795, a calcineurin-inhibitor with anti-HIV properties. J Biol Chem 1998 0.89
34 A method for determining the position and size of optimal sequence regions for phylogenetic analysis. J Mol Evol 1995 0.89
35 A RT-PCR assay for the differential diagnosis of vesicular viral diseases of swine. J Virol Methods 1998 0.89
36 Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4. J Virol 2000 0.88
37 NO induces a cGMP-independent release of cytochrome c from mitochondria which precedes caspase 3 activation in insulin producing RINm5F cells. FEBS Lett 1999 0.88
38 Hormonal regulation of fructose 2,6-bisphosphate levels in epididymal adipose tissue of rat. FEBS Lett 1985 0.87
39 Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins. J Gen Virol 1999 0.87
40 Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. Virology 1994 0.86
41 Fixation of mutations at the VP1 gene of foot-and-mouth disease virus. Can quasispecies define a transient molecular clock? Gene 1991 0.86
42 A porcine CD8+ T cell clone with heterotypic specificity for foot-and-mouth disease virus. J Gen Virol 1996 0.86
43 Specific inhibition of aphthovirus infection by RNAs transcribed from both the 5' and the 3' noncoding regions. J Virol 1994 0.85
44 Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of immunotherapy. J Allergy Clin Immunol 2001 0.85
45 Transient inhibition of foot-and-mouth disease virus infection of BHK-21 cells by antisense oligonucleotides directed against the second functional initiator AUG. Antiviral Res 1993 0.85
46 A computer program for the design of PCR primers for diagnosis of highly variable genomes. J Virol Methods 1993 0.84
47 Estimates by computer simulation of genetic distances from comparisons of RNAse A mismatch cleavage patterns. J Virol Methods 1993 0.83
48 Modulation of the inhibition of respiratory burst in mouse macrophages by cyclosporin A: effect of in vivo treatment, glucocorticoids and the state of activation of cells. Immunology 1991 0.83
49 Evidence for involvement of c-Src in the anti-apoptotic action of nitric oxide in serum-deprived RINm5F cells. Cell Signal 2001 0.83
50 Molecular epidemiology of foot-and-mouth disease virus type O. J Gen Virol 1993 0.83
51 Stable expression of antisense RNAs targeted to the 5' non-coding region confers heterotypic inhibition to foot-and-mouth disease virus infection. J Gen Virol 2003 0.82
52 Heterotypic inhibition of foot-and-mouth disease virus infection by combinations of RNA transcripts corresponding to the 5' and 3' regions. Antiviral Res 1999 0.82
53 Sodium nitroprusside-induced mitochondrial apoptotic events in insulin-secreting RINm5F cells are associated with MAP kinases activation. Exp Cell Res 2001 0.82
54 Characterization of calcineurin in human neutrophils. Inhibitory effect of hydrogen peroxide on its enzyme activity and on NF-kappaB DNA binding. J Biol Chem 1999 0.82
55 Modulation of phorbol ester-induced respiratory burst by vanadate, genistein, and phenylarsine oxide in mouse macrophages. Free Radic Biol Med 1995 0.82
56 Stimulation of glycolysis as an activation signal in rat peritoneal macrophages. Effect of glucocorticoids on this process. Biochem J 1992 0.82
57 Glucocorticoids inhibit fructose 2,6-bisphosphate synthesis in rat thymocytes. Opposite effect of cycloheximide. Biochim Biophys Acta 1991 0.82
58 IgE-dependent release of myeloperoxidase by neutrophils from allergic patients. Clin Exp Allergy 2001 0.81
59 The effect of experimental hypothyroidism on phosphofructokinase activity and fructose 2,6-bisphosphate concentrations in rat heart. Biochem J 1987 0.81
60 The inactivation of phosphorylase and activation of glycogen synthase in the adipose tissue. Eur J Biochem 1980 0.81
61 Age-related changes in membrane lipid composition, fluidity and respiratory burst in rat peritoneal neutrophils. Clin Exp Immunol 2001 0.81
62 An RT-PCR assay for the specific detection of classical swine fever virus in clinical samples. Vet Res 1998 0.80
63 Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity. Immunology 1995 0.80
64 Direct PCR detection of foot-and-mouth disease virus. J Virol Methods 1994 0.80
65 Control of fructose 2,6-bisphosphate levels in rat macrophages by glucose and phorbol ester. FEBS Lett 1989 0.80
66 Effect of prolonged fasting upon insulin and glucagon secretion from isolated rat pancreatic islets. Rev Esp Fisiol 1978 0.79
67 Decrease in free-radical production with age in rat peritoneal macrophages. Biochem J 1995 0.79
68 Thimerosal induces calcium mobilization, fructose 2,6-bisphosphate synthesis and cytoplasmic alkalinization in rat thymus lymphocytes. Biochim Biophys Acta 1991 0.79
69 A procedure for detecting selection in highly variable viral genomes: evidence of positive selection in antigenic regions of capsid protein VP1 of foot-and-mouth disease virus. J Virol Methods 1998 0.79
70 Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain. Vaccine 1992 0.79
71 Nicotinamide inhibits inducible nitric oxide synthase enzyme activity in macrophages by allowing nitric oxide to inhibit its own formation. Life Sci 1997 0.79
72 Activation of peritoneal macrophages during the prediabetic phase in low-dose streptozotocin-treated mice. FEBS Lett 1993 0.78
73 Enhancement of Antigen-specific functional responses by neutrophils from allergic patients. J Exp Med 1996 0.78
74 Gene expression profiles in the cerebellum of transgenic mice over expressing the human FMR1 gene with CGG repeats in the normal range. Genet Mol Res 2012 0.78
75 Nitric oxide and superoxide anion production decrease with age in resident and activated rat peritoneal macrophages. Cell Immunol 1996 0.78
76 Myeloperoxidase release after allergen-specific conjunctival challenge. J Asthma 2004 0.78
77 ACTH stimulates fructose 2,6-bisphosphate synthesis and glycolysis in Y-1 adrenal tumor cells. Biochem Int 1988 0.77
78 Response to retreatment with interferon-alpha plus ribavirin in chronic hepatitis C patients is independent of the NS5A gene nucleotide sequence. Am J Gastroenterol 1999 0.77
79 Short-term stimulation by adenosine of basal and insulin-induced glycogen synthesis in rat adipose tissue. Biochim Biophys Acta 1986 0.77
80 Molecular epidemiology of classical swine fever in Cuba. Virus Res 1999 0.77
81 Respiratory burst in neutrophils from asthmatic patients. J Asthma 2002 0.77
82 Inhibitory effect of interferon-alpha on respiratory burst and glucose metabolism in phagocytic cells. J Interferon Res 1994 0.77
83 Effect of thimerosal and other sulfhydryl reagents on calcium permeability in thymus lymphocytes. Biochem Pharmacol 1995 0.77
84 Analysis of the B and T cell response in guinea pigs induced with recombinant vaccinia expressing foot-and-mouth disease virus structural proteins. Arch Virol 1998 0.77
85 In vitro glucose reversal of the inhibitory effect of fasting on epinephrine-induced lipolysis. Biochem Biophys Res Commun 1981 0.77
86 Protection from nicotinamide inhibition of interleukin-1 beta-induced RIN cell nitric oxide formation is associated with induction of MnSOD enzyme activity. Endocrinology 1996 0.77
87 IgE-mediated downregulation of L-selectin (CD62L) on lymphocytes from asthmatic patients. Allergy 2001 0.77
88 Regulation of fructose-2,6-bisphosphate and glycogen synthesis by dichloroacetate and phenazine methosulphate in rat adipose tissue. Biochem Int 1986 0.76
89 Allergen-dependent CD14 modulation and apoptosis in monocytes from allergic patients. Allergy 2003 0.76
90 Identification of optimal regions for phylogenetic studies on VP1 gene of foot-and-mouth disease virus: analysis of types A and O Argentinean viruses. Vet Res 2001 0.76
91 Involvement of cyclic AMP-dependent protein kinase on the phosphorylase kinase inhibition by glucose-6-phosphate in adipose tissue extracts. Horm Metab Res 1986 0.76
92 In vitro synthesis of foot-and-mouth disease virus specific antibodies by porcine leukocytes. Arch Virol 1995 0.76
93 A newly synthesized molecule derived from ruthenium cation, with antitumour activity, activates NADPH oxidase in human neutrophils. Biochem J 1997 0.75
94 Stimulating role of potassium ions and ouabain on glycogen synthesis in adipose tissue. Biochem J 1982 0.75
95 Anti-CD69 antibodies enhance phorbol-dependent glucose metabolism and Ca2+ levels in human thymocytes. Antagonist effect of cyclosporin A. J Leukoc Biol 1996 0.75
96 Differential effect of cyclosporine A on respiratory burst by several types of human leukocytic cells. Biochem Int 1991 0.75
97 [Quasispecies and molecular evolution of viruses]. Rev Sci Tech 2000 0.75
98 Inhibitory effect of albumin-derived advanced glycosylation products on PMA-induced superoxide anion production by rat macrophages. Life Sci 1997 0.75
99 Cyclosporin A antagonizes phenylephrine, oxytocin and angiotensin effects on glucose metabolism in rat thymus lymphocytes. Biochim Biophys Acta 1994 0.75
100 Respiratory burst is decreased by human hyperlipemic serum in rat peritoneal macrophages. Free Radic Res 1996 0.75
101 RT-PCR in foot-and-mouth disease diagnosis. Vet Q 1998 0.75
102 Macrophage inducible nitric oxide synthase gene expression is blocked by a benzothiophene derivative with anti-HIV properties. Mol Genet Metab 2002 0.75
103 Streptozotocin-induced diabetes increases fructose 2,6-bisphosphate levels and glucose metabolism in rat macrophages. Biochem Med Metab Biol 1993 0.75
104 Streptozotocin-induced diabetes increases fructose 2,6-biphosphate levels and glucose metabolism in thymus lymphocytes. Life Sci 1996 0.75
105 Beta-naphthylamine induces anion superoxide production in rat peritoneal macrophages. Biochem Pharmacol 1992 0.75
106 Genomic and antigenic characterization of viruses from the 1993 Italian foot-and-mouth disease outbreak. Arch Virol 2005 0.75
107 Design and construction of African swine fever virus chimeras incorporating foreign viral epitopes. Arch Virol 1999 0.75
108 Cyclic AMP-dependent protein kinase activity and lipolysis in adipose tissue. Effect of fasting, oligomycin and iodoacetamide. Rev Esp Fisiol 1981 0.75
109 Phenylarsine oxide increases intracellular calcium mobility and inhibits Ca(2+)-dependent ATPase activity in thymocytes. Mol Genet Metab 1999 0.75
110 Activation of peritoneal macrophages during the prediabetic phase in low-dose streptozotocin-treated mice. Adv Exp Med Biol 1997 0.75
111 Plasma-cAMP concentration in fasting rats. Horm Metab Res 1979 0.75
112 May anomalous X chromosome methylation be responsible for the spontaneous abortion of a male foetus? J Genet 2008 0.75
113 Binding activity regulation of rabbit skeletal muscle adenosine 3'-5'-monophosphate-dependent protein kinases. Rev Esp Fisiol 1978 0.75